Education
About Us
Working with TipRanks
Follow Us
Oaktree Acquisition Corp. III Life Sciences Class A (OACC)
NASDAQ:OACC
OACC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.90 - $10.85
Previous CloseN/A
Volume44.20K
Average Volume (3M)20.14K
Market Cap
$50.35M
Enterprise ValueN/A
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$109.41K
Price to Earnings (P/E)―
Beta0.05
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding19,783,010
10 Day Avg. Volume23,185
30 Day Avg. Volume20,135
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oaktree Acquisition Corp. III Life Sciences Class A News
OACC FAQ
What was Oaktree Acquisition Corp. III Life Sciences Class A’s price range in the past 12 months?
Oaktree Acquisition Corp. III Life Sciences Class A lowest stock price was $9.90 and its highest was $10.85 in the past 12 months.
What is Oaktree Acquisition Corp. III Life Sciences Class A’s market cap?
Oaktree Acquisition Corp. III Life Sciences Class A’s market cap is $50.35M.
When is Oaktree Acquisition Corp. III Life Sciences Class A’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Oaktree Acquisition Corp. III Life Sciences Class A’s earnings last quarter?
Currently, no data Available
Is Oaktree Acquisition Corp. III Life Sciences Class A overvalued?
According to Wall Street analysts Oaktree Acquisition Corp. III Life Sciences Class A’s price is currently Overvalued.
Does Oaktree Acquisition Corp. III Life Sciences Class A pay dividends?
Oaktree Acquisition Corp. III Life Sciences Class A does not currently pay dividends.
What is Oaktree Acquisition Corp. III Life Sciences Class A’s EPS estimate?
Oaktree Acquisition Corp. III Life Sciences Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oaktree Acquisition Corp. III Life Sciences Class A have?
Oaktree Acquisition Corp. III Life Sciences Class A has 19,783,010 shares outstanding.
What happened to Oaktree Acquisition Corp. III Life Sciences Class A’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Oaktree Acquisition Corp. III Life Sciences Class A?
Currently, no hedge funds are holding shares in OACC
Company Description
Oaktree Acquisition Corp. III Life Sciences Class A
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Oaktree Acquisition Corp. III Life Sciences Class A (OACC) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
dMY Squared Technology Group, Inc. Class A
―
AlphaVest Acquisition Corporation
―
Horizon Space Acquisition I Corporation
―
Four Leaf Acquisition Corporation Class A
―
Quetta Acquisition Corp.
―
Ownership Overview
―
Insiders
4.51% Mutual Funds
2.02% Other Institutional Investors
93.03% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---